Poor glycemic control increases risk of hospitalization in urban african americans with diabetes

Ethnicity and Disease

Volumn 16, Issue 4, 2006, Pages 880-885

  Cook, Curtiss B ^a   Hentz, Joseph G ^a   Tsui, Circe ^b   Ziemer, David C ^b   Naylor, Dorothy B ^c   Miller, William J ^d  

^a MAYO CLINIC   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Georgia Regional Hospital   (United States)

^d WESTERN CAROLINA UNIVERSITY   (United States)

Author keywords

African American; Diabetes; Hospitalizations

Indexed keywords

BIOLOGICAL MARKER; CREATININE; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; AFRICAN AMERICAN; AGED; ALBUMINURIA; ARTICLE; BLOOD; BLOOD PRESSURE; COMPARATIVE STUDY; EPIDEMIOLOGY; ETHNOLOGY; FEMALE; GLUCOSE BLOOD LEVEL; HOSPITALIZATION; HUMAN; MALE; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICAL MODEL; STATISTICS; UNITED STATES; URBAN POPULATION; URINE;

ADOLESCENT; ADULT; AFRICAN AMERICANS; AGED; ALBUMINURIA; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD PRESSURE; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CONFOUNDING FACTORS (EPIDEMIOLOGY); CREATININE; DIABETES MELLITUS, TYPE 2; FEMALE; GEORGIA; HEMOGLOBIN A, GLYCOSYLATED; HOSPITALIZATION; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; TRIGLYCERIDES; URBAN POPULATION;

EID: 36048954532     PISSN: 1049510X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Engelgau MM, Geiss LS, Saaddine JB, et al. The evolving diabetes burden in the United States. Ann Intern Med. 2004;140:945-950.
2. Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2003;289:76-79.
3. Wild S, Roglic G, Green A, Sicree R, Hilary K. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047-1053.
4. Boyle JP, Honeycutt AA, Venkat Narayan KM, et al. Projection of diabetes burden through 2050. Diabetes Care. 2001;24:1936-1940.
5. Aubert RE, Geiss LS, Ballard DJ, Cocanougher B, Herman WH. Diabetes-related hospitalization and hospital utilization. In: Diabetes in America. Bethesda, Md: National Institutes of Diabetes and Digestive Diseases; 1995:553-563.
6. Elixhauser A, Yu K, Steiner C, Bierman AS. Hospitalization in the United States, 1997. Rockville, Md: Agency for Healthcare Research and Quality; 2000.
7. Centers for Disease Control and Prevention. Hospitalizations for Diabetes as Any-Listed Diagnosis. Atlanta, Ga: CDC; 2004.
8. Centers for Disease Control Prevention. Hospitalization for Diabetes as First-Listed Diagnosis. Atlanta, Ga: CDC; 2004.
9. Jiang HJ, Stryer D, Friedman B, Andrews R. Multiple hospitalizations for patients with diabetes. Diabetes Care. 2003;26:1421-1426.
10. American Diabetes Association. Economic costs of diabetes in the US in 2002. Diabetes Care. 2003;26:917-932.
11. Carter JS, Pugh JA, Monterrosa A. Non-insulin-dependent diabetes mellitus in minorities in the United States. Ann Intern Med. 1996;125:221-232. (Pubitemid 126449266)
12. Centers for Disease Control and Prevention Division of Disease Translation. 1999 Diabetes Surveillance Report. Atlanta, Ga: CDC, Dept of Health and Human Services; 2000.
13. Elixhauser A, Harris R, Coffey RM. Trends in Hospital Diagnoses for Black Patients and White Patients: 1980-1987. Rockville, Md: Public Health, Agency for Health Care Policy and Research; 1995. Service Provider Studies Research Note 24.
14. Davis SK, Liu Y, Gibbons GH. Disparities in trends of hospitalization for potentially preventable chronic conditions among African Americans during the 1990s: implications and benchmarks. Am J Public Health. 2003;93:447-455. (Pubitemid 36255191)
15. Cook CB, Naylor DB, Hentz JG, et al. Disparities in diabetes-related hospitalizations: relationship of age, sex, and race/ethnicity with hospital discharges, lengths of stay, and direct inpatient charges. Ethn Dis. 2006;16(1):126-131.
16. Cook CB, Tsui C, Ziemer DC, Naylor DB, Miller WJ, Hentz JG. Common reasons for hospitalization in urban diabetes patients. Ethn Dis. 2006;16(2):391-397. (Pubitemid 46952637)
17. Ziemer DC, Goldschmid M, Musey VC, et al. Diabetes in urban African Americans. III. Management of type II diabetes in a municipal hospital setting. Am J Med. 1996;101:25-33. (Pubitemid 26285937)
18. Wheeler K, Crawford R, McAdams D, et al. Inpatient to outpatient transfer of care in urban diabetes patients: patterns and determinants of immediate post-discharge follow-up. Arch Intern Med. 2004;164:447-453. (Pubitemid 38240711)
19. Rhee MK, Cook CB, Dunbar VG, et al. Limited healthcare access impairs glycemic control in urban African Americans with type 2 diabetes. J Health Care Poor Underserved. 2005;16:734-746.
20. Thaler LM, Ziemer DC, Gallina DL, et al. Diabetes in urban African Americans. XVII. Availability of rapid hemoglobin A1C measurements enhances clinical decision-making (abstract). Diabetes. 1999;48:A191.
21. Cook CB, Ziemer DC, El-Kebbi IM, et al. Diabetes in urban African Americans. XVI. Overcoming clinical inertia improves glycemic control in patients with type 2 diabetes. Diabetes Care. 1999;22:1494-1500.
22. Thaler LM, Ziemer DC, El-Kebbi IM, Gallina DL, Cook CB, Phillips LS. Diabetes in urban African Americans. XIX. Prediction of the need for pharmacological therapy. Diabetes Care. 2000;23:820-825.
23. Cook CB, Erdman DE, Ryan GJ, et al. The pattern of dyslipidemia among urban African Americans with type 2 diabetes. Diabetes Care. 2000;23:319-324.
24. Cook CB, Mann LJ, King EC, et al. Management of insulin therapy in urban diabetes patients is facilitated by use of an intelligent dosing system. Diabetes Technol Ther. 2004;6:326-335.
25. Rhee MK, Slocum W, Ziemer DC, et al. Patient adherence improves glycemic control. Diabetes Educator. 2005;31:240-250. (Pubitemid 40529013)
26. Dunbar VG, King EC, George CD, et al. Evolving demographics and disparities in an urban diabetes clinic: implications for diabetes education and treatment. Ethn Dis. 2005;15:173-178.
27. Thaler LM, El-Kebbi IM, Ziemer DC, et al. High prevalence of albuminuria among African Americans with short duration of diabetes [letter]. Diabetes Care. 1998;21:1576-1577.
28. Lang TA, Secic M. Determining the Presence or Absence of Disease: Reporting the Characteristics of a Diagnostic Test. Philadelphia, Pa: American College of Physicians; 1997.
29. Anonymous. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352:837-853.
30. Anonymous. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352:854-865.
31. Menzin J, Langley-Hawthorne C, Friedman M, Boulanger L, Cavanaugh R. Potential short-term economic benefits of improved glycemic control. Diabetes Care. 2001;24:51-55.
32. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications of insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-986.
33. Testa MA, Simonson DC. Health economic benefits and quality of life during improved glycemic control in patients with type 2 diabetes mellitus. JAMA. 1998;280:1490-1496.
34. Wake N, Hisashige A, Katayama T, et al. Cost-effectiveness of intensive insulin therapy for type 2 diabetes: a 10-year follow-up of the Kumamoto study. Diabetes Res Clin Pract. 2000;48:201-210. (Pubitemid 30232841)
35. Wagner EH, Sandhu N, Newton KM, McCulloch DK, Ramsey SD, Gorthaus LC. Effect of improved glycemic control on healthcare costs and utilization. JAMA. 2001;285:182-189. (Pubitemid 32048520)